PerpEquitiesReference market
Closed- Regular hours
- 09:30 AM – 04:00 PM
- Next holiday
- Nov 26, 2026 · Thanksgiving Day
Equity
Eli Lilly and Company (LLY) perpetual futures
LLY perpetual futures on 21 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade LLYUSDT.
Eli Lilly and Company develops and commercializes human medicines in diabetes, oncology, immunology, neurology, and other therapeutic areas, including collaborations with partners.
$1,189+0.1%NYSE closed
Price chart
–
Use the left and right arrow keys to inspect points on the chart.
Collecting venue price data...
venue perp mark · Deepcoin (LLY/USDT)
Auto: highest-volume live perp venueOpen in TradingView
Trading data
Perpetual market activity
21/21 live markets
Trading data
Perpetual market activity
Venues
21
Live markets
21/21
24h volume
$19.8MCoverage: 17/21 marketsExchange-reported volume: $25.3M
Open interest
$26.4MCoverage: 15/21 markets
Best liquidity
$888.8K
BingX
Tightest spread
+0.1 bps
LBank
Highest volume
$8.2M
Deepcoin
Settlement mix
USDT · 17/21
Perp/spot vol.
0.01x
Spot volume $2.3B
OI / float
0.00%
Float $1T
Spot performance
1D+0.21%
5D+0.96%
1M+0.97%
6M+35.04%
YTD+10.36%
1Y+63.24%
Venue matrix
21 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
| Trade | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Deepcoin | Trade | LLY/USDT | Trading | $1,188 | - | +2.8 bps | $38.4K | $8.2M | - | USDT | 25x | |
 Hyperliquid HIP-3 | Trade | xyz:LLY | Trading | $1,188 | +21.7% APR +0.00248% every 1h | +5.0 bps | $243.8K | $4.4M | $11.1M | USDC | 10x | |
 Binance | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +2.5 bps | - | $3.3M | $1.4M | USDT | - | |
 LBank | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +0.1 bps | $637.6K | $1.2M | - | USDT | 50x | |
 Bybit | Trade | LLY/USDT | Trading | $1,188 | 0.0% APR 0.000% every 8h | +3.0 bps | $52.7K | $700.6K | $1.5M | USDT | 25x | |
 XT.com | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +2.0 bps | $61.1K | $633.9K | $2.1M | USDT | 20x | |
 Gate.io | Trade | LLY/USDT | Trading | $1,188 | 0.0% APR 0.000% every 8h | +2.4 bps | - | $407.8K | $1.3M | USDT | 25x | |
 OKX | Trade | LLY/USDT | Trading | $1,188 | 0.0% APR 0.000% every 8h | +10.1 bps | $39.7K | $278.4K | $669.2K | USDT | 20x | |
 Bitget | Trade | LLY/USDT | Trading | $1,190 | 0.0% APR 0.000% every 8h | +0.6 bps | - | $197.8K | $2.3M | USDT | 20x | |
 Bitunix | Trade | LLY/USDT | Trading | $1,189 | +0.3% APR +0.00024% every 8h | +0.1 bps | $427.7K | $180.9K | - | USDT | 50x | |
 GRVT | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +4.6 bps | $25K | $102.6K | $1.2K | USDT | - | |
 MEXC | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +2.5 bps | $300K | $100.3K | $5.6M | USDT | 100x | |
 Helix (Injective) | Trade | LLY/USDC | Trading | $1,188 | +24.1% APR +0.00275% every 1h | - | - | $87.1K | - | USDC | 12x | |
 BloFin | Trade | LLY/USDT | Trading | $1,189 | +2.0% APR +0.00179% every 8h | +2.2 bps | $61.2K | $79.8K | $79.4K | USDT | 20x | |
 HTX | Trade | LLY/USDT | Trading | $1,188 | - | +45.6 bps | $44.4K | $56.2K | - | USDT | - | |
 Aster | Trade | LLYUSDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +99.8 bps | $16.9K | $7.1K | $26.6K | USDT | - | |
 Crypto.com Exchange | Trade | LLY/USD | Trading | $1,184 | +81.0% APR +0.00925% every 1h | +12.8 bps | $14.9K | $3.1K | $8.6K | USD | 50x | |
 Vest | Trade | LLY/USDC | Trading | $1,188 | +5.0% APR +0.00057% every 1h | +14.6 bps | $34.2K | - | - | USDC | 25x | |
 Ourbit | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +2.7 bps | - | $2.1M⚠ | $176.7K | USDT | 100x | |
 KuCoin | Trade | LLY/USDT | Trading | $1,189 | 0.0% APR 0.000% every 8h | +21.0 bps | $1.7K | $1.7M⚠ | $156.8K | USDT | 20x | |
 BingX | Trade | LLY-USDT | Trading | $1,189 | +5.5% APR +0.00500% every 8h | +2.7 bps | $888.8K | $1.7M⚠ | $1.2K | USDT | - |
Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.
Tokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| LLYonOndo GM | $1,193 | +0.35% | $3.1M | $5.2M | Ethereum · BNB Smart Chain (BEP20) · Solana |
| LLYRobinhood | $1,188 | -0.08% | $1.3M | $1.0M | Robinhood Chain |
| LLYXxStocks | $1,187 | -0.18% | $162k | $1.0M | Solana · Arbitrum · BNB Smart Chain (BEP20) · Ink |
| rLLYTokenized | $1,187 | -0.13% | $16k | $64k | Arbitrum |
| WLLYXxStocks | $1,197 | +0.69% | – | $10k | X Layer · Arbitrum |
| Exchange | Pair | Price | 24h Vol. | Liquidity |
|---|---|---|---|---|
 uniswapDEX · robinhood | LLY/USDG ↗ | $1,188 | $1.3M | $330k |
| gateioCEX | LLYON/USDT ↗ | $1,192 | $123k | – |
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kBroad liquidity · 11 of 21 venues absorb $10k · Typical cost: +10.2 bps – +31.6 bps
Cheapest execution: Bitunix · +7.1 bps
Too thin: GRVT, Aster, Crypto.com Exchange, KuCoin
No fresh book data: LBank, Binance, Ourbit, Gate.io, Bitget, Helix (Injective)
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
LLYTightest spread
LLYHighest volume
LLYFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 2h ago
Company data
Company fundamentals
Market cap
$1.1T
Updated 2h ago
Revenue
$79.7B
Trailing 12 months
Revenue growth
+36%
Next fiscal year
Profit margin
+33.5%
P/E
39.7
Peer P/E 13.6
Free cash flow
$20.1B
Trailing 12 months
More metrics
Net income
$26.7B
Trailing 12 months
P/S
14.0
Peer P/E
13.6
Similar listed perps
Revenue estimate
$88.5B
Next fiscal year
Earnings
2026-10-29
Revenue est. $22.3B · Updated 2h ago
Dividend
$1.73
2026-08-14
Fundamental detail
Annual + quarterlyLatest revenue$65.2B
Net margin+31.7%
Free cash flow$9B
Net debt$35.3B
PeriodRevenueGrowthNet incomeFCF
2020$24.5B+10%$6.2B$4.5B
2021$28.3B+15%$5.6B$5.4B
2022$28.5B+1%$6.2B$4.6B
2023$34.1B+20%$5.2B-$3.2B
2024$45B+32%$10.6B$414.3M
2025$65.2B+45%$20.6B$9B
PeriodGross marginOperating marginNet marginROEROA
2020+77.7%+29.4%+25.2%+109.8%+13.3%
2021+74.2%+28.0%+19.7%+62.2%+11.4%
2022+76.8%+30.3%+21.9%+58.6%+12.6%
2023+79.2%+31.6%+15.4%+48.6%+8.2%
2024+81.3%+37.8%+23.5%+74.6%+13.5%
2025+83.0%+45.6%+31.7%+77.8%+18.4%
PeriodCashDebtNet debtCurrent ratio
2020$3.7B$16.6B$12.9B1.40
2021$3.8B$16.9B$13.1B1.23
2022$2.1B$16.2B$14.2B1.05
2023$2.8B$25.2B$22.4B0.94
2024$3.3B$33.6B$30.4B1.15
2025$7.2B$42.5B$35.3B1.58
PeriodMarket capEnterprise valueP/SP/E
2020$161.5B$174.4B6.626.1
2021$263.4B$276.5B9.347.2
2022$347.6B$361.8B12.255.7
2023$524.3B$546.7B15.4100.0
2024$695.3B$725.6B15.465.6
2025$965.1B$1T14.846.6
PeriodRevenueGrowthNet incomeFCF
Q3 2024$11.4B+20%$970.3M-$458.9M
Q4 2024$13.5B+45%$4.4B$726.6M
Q1 2025$12.7B+45%$2.8B-$1.6B
Q2 2025$15.6B+38%$5.7B$1.3B
Q3 2025$17.6B+54%$5.6B$8.6B
Q4 2025$19.3B+43%$6.6B$677.9M
Q1 2026$19.8B+56%$7.4B$3B
Q2 2026$23B+48%$7.1B$7.8B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+81.0%+38.8%+8.5%+6.8%+1.3%
Q4 2024+82.2%+42.0%+32.6%+31.1%+5.6%
Q1 2025+82.5%+41.7%+21.7%+17.5%+3.1%
Q2 2025+84.3%+45.1%+36.4%+31.0%+5.6%
Q3 2025+82.9%+47.6%+31.7%+23.5%+4.9%
Q4 2025+82.5%+46.6%+34.4%+25.0%+5.9%
Q1 2026+81.9%+49.4%+37.4%+23.7%+6.3%
Q2 2026+85.8%+54.2%+30.9%+20.9%+5.0%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$3.4B$31.1B$27.8B1.27
Q4 2024$3.3B$33.6B$30.4B1.15
Q1 2025$3.1B$38.5B$35.4B1.37
Q2 2025$3.4B$39.9B$36.5B1.28
Q3 2025$9.8B$42.5B$32.7B1.55
Q4 2025$7.2B$42.5B$35.3B1.58
Q1 2026$5.1B$43.4B$38.2B1.50
Q2 2026$8.9B$54.9B$46B1.35
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$798.2B$826B69.8205.1
Q4 2024$692.9B$723.3B51.239.3
Q1 2025$741.7B$777.1B58.367.3
Q2 2025$699.9B$736.5B45.030.9
Q3 2025$684.3B$717B38.930.6
Q4 2025$965.1B$1T50.036.2
Q1 2026$822.7B$861B41.627.8
Q2 2026$1.1T$1.1T46.637.7
Refreshed 2h ago
Charts: revenue, profit, cash flow & valuation
CashDebt
Gross marginOperating marginNet margin
P/EP/S
CashDebt
Gross marginOperating marginNet margin
P/EP/S
Next catalyst
Catalysts
Next catalyst
Catalysts
Earnings
2026-10-29
Revenue est. $22.3B · Updated 2h ago
Dividend
$1.73
2026-08-14
No unusual perp activity right now.
FMP reference data
Market context
FMP reference data
Market context
New York Stock Exchange
After-hours reference
Bid1,185.75
Ask1,195
Volume1,974,029
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6DateEPS estimateRevenue estimateGrowthAnalysts
FY 202636.58$88.5B+36%15
FY 202746.92$102.2B+57%15
FY 202853.87$114.1B+75%9
FY 202960.97$123.4B+89%3
FY 203066.89$132.9B+104%3
Q3 20269.92$22.3B+27%10
Company events
62026-10-29EarningsActual - / Estimate 9.92-
2026-08-14Dividend$1.73-
2026-08-05EarningsActual 8.38 / Estimate 6.4Beat
2026-05-15Dividend$1.73-
2026-04-30EarningsActual 8.55 / Estimate 6.97Beat
2026-02-13Dividend$1.73-
Peer comparison
Similar listed perpsRevenue mix
PendingSegment data is not available yet.
Analysts
PendingNo analyst data available yet.
Ownership
LLY-PERPOwnership data is being populated.
Filings
PendingNo filings available yet.
Transcripts
PendingNo transcripts available yet.
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
FMP company data
Company intelligence
Updated: Sep 29, 2026, 06:37 AM UTC
FMP company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- David A. Ricks
- Employees
- 50,000
- IPO date
- Jun 1, 1972
- Country
- US
- Exchange
- New York Stock Exchange
Altman Z-scorei8.14
Piotroski scorei8/9
FMP ratingiB
Owner earningsi$10.47B$11.72 per share
ESG risk ratingiB+Industry rank: 10 out of 28
Rating factors
- Return on equityi
- 5
- Return on assetsi
- 5
- Debt to equityi
- 1
- Price to earningsi
- 1
- Price to booki
- 1
Company press releases
Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICsPRNewsWireFDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areataPRNewsWireLilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020PRNewsWireU.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancerPRNewsWireLilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditionsPRNewsWireLilly to participate in Morgan Stanley 24th Annual Global Healthcare ConferencePRNewsWire
Congressional disclosures
Senate
Angus Stanley KingSale · $1,001 - $15,000Disclosed: Mar 24, 2026Angus KingSale · $1,001 - $15,000Disclosed: Mar 24, 2026Angus Stanley KingPurchase · $1,001 - $15,000Disclosed: Jan 26, 2026Angus Stanley KingPurchase · $1,001 - $15,000Disclosed: Jan 26, 2026Markwayne MullinPurchase · $15,001 - $50,000Disclosed: Jan 16, 2026
House
Daniel Milton NewhouseSale (Partial) · $1,001 - $15,000Disclosed: Jul 20, 2026Daniel Milton NewhouseSale · $1,001 - $15,000Disclosed: Jul 20, 2026Dan NewhouseSale · $1,001 - $15,000Disclosed: Jul 20, 2026Daniel Milton NewhouseSale (Partial) · $1,001 - $15,000Disclosed: Jul 20, 2026Michael A. RulliSale · $1,001 - $15,000Disclosed: Aug 10, 2026
Market cap history
$1.06T-3.5%Jun 26 – Sep 26
Latest: $1.06T · 2026-09-28High: $1.11T · 2026-08-24Low: $1.00T · 2026-08-03
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTS.AX | 1.33% | 27.5M |
| VTI | 1.33% | 26.9M |
| VOO | 1.38% | 21M |
| VCPA.S | 0.36% | 16.9M |
| IVV | 1.42% | 10.6M |
| 1657.T | 1.09% | 10.6M |
| XAW.TO | 0.84% | 10.6M |
| XUU.TO | 1.27% | 10.6M |
| XWD.TO | 1.03% | 10.6M |
| FXAIX | 1.41% | 9.9M |
| 1557.T | 1.39% | 9.9M |
| SPY | 1.42% | 9.8M |
Analyst track record
How the analysts covering LLY have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 278 | 831 |
| Analysts | 31 | 42 |
| Buy / hold / sell | 256 / 19 / 3 | 761 / 66 / 4 |
| Upgrades / downgrades / initiations | 6 / 1 / 3 | 12 / 8 / 9 |
| Price targets hit / missed | 58 / 194 (23%) | 519 / 213 (71%) |
| Avg. return after a rating (TipRanks) | -4.8% | +19.5% |
| Best / worst call | +65.3% / -26.1% | +189.7% / -26.1% |
After buy calls on this stock: median 21-day move +1.5% vs S&P 500 -1.0% (n = 757)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Louise ChenScotiabank100% hit rate on this stock · 19 targets measuredBuytarget $1,300Aug 6, 2026
- Asad HaiderGoldman Sachs100% hit rate on this stock · 10 targets measuredBuytarget $1,367Aug 6, 2026
- Courtney BreenBernstein97% hit rate on this stock · 29 targets measuredBuytarget $1,385Aug 31, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 28, 2026 | Chris SchottJ.P. Morgan | BuyMaintained | $1,500 | article ↗ |
| Sep 28, 2026 | Emily FieldBarclays | BuyMaintained | $1,400 | article ↗ |
| Sep 23, 2026 | Umer RaffatEvercore ISI | HoldMaintained | – | article ↗ |
| Sep 23, 2026 | Umer RaffatEvercore ISI | HoldMaintained | – | |
| Sep 22, 2026 | Akash TewariJefferies | BuyMaintained | $1,440 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Sep 28, 2026 · 278 ratings
Frequently asked questions
Where can I trade LLY perpetual futures?
Eli Lilly and Company (LLY) perpetual futures trade on 21 crypto venues, including Deepcoin, Hyperliquid HIP-3, Binance. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade LLY around the clock?
Yes. Unlike the underlying stock, LLY perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on LLY perpetuals?
Right now the LLY perp funding rate is +10.9% annualized (venue median), ranging from 0.0% to +21.7% across 21 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the LLY perp price compare to the Eli Lilly and Company stock?
The venue-median LLY perp mark is $1.2K versus a reference stock price of $1.2K, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a LLY perpetual future?
A LLY perpetual is a derivative that tracks the price of Eli Lilly and Company with no expiry date. It lets you take long or short exposure to Eli Lilly and Company on crypto venues, around the clock.
What is LLYUSDT perpetual?
LLYUSDT is the symbol most crypto exchanges use for the Eli Lilly and Company perpetual settled in USDT (Tether). It tracks the LLY share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/lly-perp"><img src="https://perpequities.com/badge/lly-perp.svg" width="240" height="64" alt="LLY perpetuals · perpequities.com" loading="lazy"></a>